Policy & Regulation
Wolters Kluwer Highlights Patients as Underutilised Resource in the Fight against Sepsis
18 September 2018 - - Dutch information services company Wolters Kluwer, Health highlights the critical role of patients, as 4,000 hospitals in the US react to public reporting of sepsis qua...
Supernus agrees to acquire Biscayne Neurotherapeutics
18 September 2018 - Supernus Pharmaceuticals Inc (NASDAQ:SUPN) has entered into an agreement to acquire Biscayne Neurotherapeutics, a privately-held company developing a novel treatment for epilepsy, ...
Navidea Biopharmaceuticals completes USD3m in private placement
18 September 2018 - Biopharmaceutical company Navidea Biopharmaceuticals Inc (NYSE American:NAVB) reported on Monday the completion of USD3m private placement under a definitive securities purchase ag...
Agenus awarded USD5m in milestone payment for initiation of Phase 1 trial of LAG-3 antibody
18 September 2018 - Immuno-oncology company Agenus Inc (NASDAQ:AGEN) on Monday announced that Incyte has made a cash milestone payment of USD5m for the initiation of its Phase 1 clinical trial of INCA...
Tikcro Technologies incurs lower net loss of USD341,000 for Q2 2018
18 September 2018 - Cancer immune-therapy company Tikcro Technologies Ltd (OTCQB:TIKRF) stated on Monday that it recorded a net loss of USD341,000 (USD0.03 per diluted share) for the second quarter en...
Sensus Healthcare raises USD15m from public offering
18 September 2018 - Medical company Sensus Healthcare Inc (Nasdaq:SRTS ) revealed on Monday the completion of its public offering of 2,205,882 common stock, par value USD0.01 per share.All of the comm...